GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (NSE:EPIGRAL) » Definitions » Total Equity

Epigral (NSE:EPIGRAL) Total Equity : ₹12,541 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Epigral Total Equity?

Epigral's total equity for the quarter that ended in Mar. 2024 was ₹12,541 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Epigral Total Equity Historical Data

The historical data trend for Epigral's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Total Equity Chart

Epigral Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Equity
Get a 7-Day Free Trial 5,834.71 6,841.34 7,259.70 10,691.00 12,541.01

Epigral Quarterly Data
Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,691.00 - 11,283.30 - 12,541.01

Epigral Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Epigral's Total Equity for the fiscal year that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=27943.416-15402.409
=12,541

Epigral's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=27943.416-15402.409
=12,541

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epigral Total Equity Related Terms

Thank you for viewing the detailed overview of Epigral's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigral (NSE:EPIGRAL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (NSE:EPIGRAL) » Definitions » Total Equity
Comparable Companies
BOM:506222 BOM:500339 BOM:530001 BOM:500052 BOM:500150 BOM:500201 BOM:500171 BOM:500117 BOM:506618 BOM:500199 SAU:2010 TSE:4063 XTER:BAS DOW XKRX:051910 SZSE:002493 SHSE:600989 CE XKLS:5183 XKRX:086520
Traded in Other Exchanges
543332:India
Address
Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015
Website
https://www.meghmanifinechem.com
Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (NSE:EPIGRAL) Headlines

No Headlines